Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, Jiangsu 210029, China.
Chin Med J (Engl). 2022 Feb 2;135(5):557-570. doi: 10.1097/CM9.0000000000001870.
Cardiovascular disease (CVD) remains the leading cause of death worldwide. Therefore, exploring the mechanism of CVDs and critical regulatory factors is of great significance for promoting heart repair, reversing cardiac remodeling, and reducing adverse cardiovascular events. Recently, significant progress has been made in understanding the function of protein kinases and their interactions with other regulatory proteins in myocardial biology. Protein kinases are positioned as critical regulators at the intersection of multiple signals and coordinate nearly every aspect of myocardial responses, regulating contractility, metabolism, transcription, and cellular death. Equally, reconstructing the disrupted protein kinases regulatory network will help reverse pathological progress and stimulate cardiac repair. This review summarizes recent researches concerning the function of protein kinases in CVDs, discusses their promising clinical applications, and explores potential targets for future treatments.
心血管疾病(CVD)仍然是全球范围内的主要死亡原因。因此,探索 CVD 的机制和关键调节因子对于促进心脏修复、逆转心脏重构和减少不良心血管事件具有重要意义。最近,人们对蛋白激酶的功能及其与心肌生物学中其他调节蛋白的相互作用有了更深入的了解。蛋白激酶作为关键调节因子处于多种信号的交汇点,协调心肌反应的几乎所有方面,调节收缩性、代谢、转录和细胞死亡。同样,重建失调的蛋白激酶调节网络将有助于逆转病理进展并刺激心脏修复。本综述总结了蛋白激酶在 CVD 中的功能的最新研究,讨论了其在临床应用中的广阔前景,并探讨了未来治疗的潜在靶点。